This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1996 Aug 22;335(8):596-7; author reply 597.

doi: 10.1056/NEJM199608223350814.

Effect of benazepril in chronic renal insufficiency

A J Apperloo, P L Rensma

PMID: 8684417
DOI: 10.1056/NEJM199608223350814

Comment

Effect of benazepril in chronic renal insufficiency

A J Apperloo et al. N Engl J Med. 1996.

. 1996 Aug 22;335(8):596-7; author reply 597.

doi: 10.1056/NEJM199608223350814.

Authors

A J Apperloo, P L Rensma

PMID: 8684417
DOI: 10.1056/NEJM199608223350814

No abstract available

PubMed Disclaimer

Comment on

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.
Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, Ponticelli C, Ritz E, Zucchelli P. Maschio G, et al. N Engl J Med. 1996 Apr 11;334(15):939-45. doi: 10.1056/NEJM199604113341502. N Engl J Med. 1996. PMID: 8596594 Clinical Trial.

Similar articles

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.
Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, Ponticelli C, Ritz E, Zucchelli P. Maschio G, et al. N Engl J Med. 1996 Apr 11;334(15):939-45. doi: 10.1056/NEJM199604113341502. N Engl J Med. 1996. PMID: 8596594 Clinical Trial.
Effect of benazepril in chronic renal insufficiency.
Curren CG. Curren CG. N Engl J Med. 1996 Aug 22;335(8):597; author reply 597. N Engl J Med. 1996. PMID: 8684418 No abstract available.
Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
Ruilope LM, Aldigier JC, Ponticelli C, Oddou-Stock P, Botteri F, Mann JF. Ruilope LM, et al. J Hypertens. 2000 Jan;18(1):89-95. J Hypertens. 2000. PMID: 10678548 Clinical Trial.
[Renoprotective effects of antihypertensives].
Monhart V. Monhart V. Vnitr Lek. 2004 Jul;50(7):531-6. Vnitr Lek. 2004. PMID: 15323261 Review. Czech.
[Nephroprotection by inhibition of the renin-angiotensin system--wish or reality?].
Barnas U, Mayer G. Barnas U, et al. Wien Klin Wochenschr. 1995;107(1):10-4. Wien Klin Wochenschr. 1995. PMID: 7871784 Review. German.

See all similar articles

Cited by

Interventions for preventing the progression of autosomal dominant polycystic kidney disease.
St Pierre K, Cashmore BA, Bolignano D, Zoccali C, Ruospo M, Craig JC, Strippoli GF, Mallett AJ, Green SC, Tunnicliffe DJ. St Pierre K, et al. Cochrane Database Syst Rev. 2024 Oct 2;10(10):CD010294. doi: 10.1002/14651858.CD010294.pub3. Cochrane Database Syst Rev. 2024. PMID: 39356039
Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease.
Natale P, Palmer SC, Navaneethan SD, Craig JC, Strippoli GF. Natale P, et al. Cochrane Database Syst Rev. 2024 Apr 29;4(4):CD006257. doi: 10.1002/14651858.CD006257.pub2. Cochrane Database Syst Rev. 2024. PMID: 38682786 Free PMC article.
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
Cooper TE, Teng C, Tunnicliffe DJ, Cashmore BA, Strippoli GF. Cooper TE, et al. Cochrane Database Syst Rev. 2023 Jul 19;7(7):CD007751. doi: 10.1002/14651858.CD007751.pub3. Cochrane Database Syst Rev. 2023. PMID: 37466151 Free PMC article.
Interventions for preventing the progression of autosomal dominant polycystic kidney disease.
Bolignano D, Palmer SC, Ruospo M, Zoccali C, Craig JC, Strippoli GF. Bolignano D, et al. Cochrane Database Syst Rev. 2015 Jul 14;2015(7):CD010294. doi: 10.1002/14651858.CD010294.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2024 Oct 2;10:CD010294. doi: 10.1002/14651858.CD010294.pub3. PMID: 26171904 Free PMC article. Updated.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information